NCT07520409 Effects of Drawing in Maneuver and Resisted Ankle Dorsiflexion in Postpartum Diastasis Recti
| NCT ID | NCT07520409 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Diastasis Recti |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2025-10-01 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to compare the combine effects of drawing in maneuver and resisted ankle dorsiflexion on pain, inter-recti distance, strength and quality of life in postpartum diastasis recti.
Eligibility Criteria
Inclusion Criteria: * Postpartum females (6 weeks to 6 months postpartum) * Diagnosed with diastasis recti (IRD ≥ 2.5 cm) * Age 20-45 years * Mode of delivery * Multiparity Exclusion Criteria: * History of abdominal surgery * Pelvic organ prolapses * Neurological or orthopedic disorders * Presence of low back pain, hernia, or musculoskeletal disorders * Participation in any other abdominal rehabilitation program in the last 3 months
Contact & Investigator
hina gul, PhD*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07520409 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Diastasis Recti. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07520409 currently recruiting?
Yes, NCT07520409 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07520409 trial being conducted?
This trial is being conducted at Guiranwala, Pakistan.
Who is sponsoring the NCT07520409 clinical trial?
NCT07520409 is sponsored by Riphah International University. The principal investigator is hina gul, PhD* at Riphah International University. The trial plans to enroll 42 participants.